↓ Skip to main content

Aripiprazole versus typical antipsychotic drugs for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, July 2008
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (67th percentile)

Mentioned by

twitter
6 tweeters
weibo
1 weibo user

Citations

dimensions_citation
41 Dimensions

Readers on

mendeley
96 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Aripiprazole versus typical antipsychotic drugs for schizophrenia
Published in
Cochrane database of systematic reviews, July 2008
DOI 10.1002/14651858.cd006617.pub3
Pubmed ID
Authors

Jayanti Bhattacharjee, Hany G El-Sayeh

Abstract

Aripiprazole is a relatively new antipsychotic drug, said to be the prototype of a new third generation of antipsychotics; the so-called dopamine-serotonin system stabilisers. In this review we examine how the efficacy and tolerability of aripiprazole differs from that of typical antipsychotics.

Twitter Demographics

The data shown below were collected from the profiles of 6 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 96 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 2 2%
Unknown 94 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 20 21%
Researcher 18 19%
Student > Doctoral Student 10 10%
Student > Bachelor 9 9%
Student > Ph. D. Student 8 8%
Other 31 32%
Readers by discipline Count As %
Medicine and Dentistry 43 45%
Psychology 13 14%
Unspecified 12 13%
Nursing and Health Professions 6 6%
Neuroscience 4 4%
Other 18 19%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 March 2017.
All research outputs
#3,639,773
of 12,527,093 outputs
Outputs from Cochrane database of systematic reviews
#5,959
of 8,923 outputs
Outputs of similar age
#79,535
of 286,550 outputs
Outputs of similar age from Cochrane database of systematic reviews
#175
of 223 outputs
Altmetric has tracked 12,527,093 research outputs across all sources so far. This one is in the 49th percentile – i.e., 49% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 286,550 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 223 others from the same source and published within six weeks on either side of this one. This one is in the 19th percentile – i.e., 19% of its contemporaries scored the same or lower than it.